Table 1: Triage & Prioritization of breast tumour cases for surgery tailored to local case-mix (adapted from ACS [11], ESMO [12]) (ACS-American College of Surgeons, ESMO-European Society of Medical Oncology).
Breast tumour | |
High priority | Completed post-neoadjuvant chemotherapy |
Complications of prior breast cancer surgery with bleeding or infection requiring re-intervention | |
Complications from reconstructive surgery | |
Breast cancer diagnosed in pregnancy | |
Unusual cases for special considerations: Patients with progressive disease on systemic therapy, angiosarcoma, and malignant phyllodes, bleeding/ruptured tumours |
|
Triple negative /HER2+* | |
High grade DCIS | |
Discordant biopsy of likely to be malignant | |
Medium priority | Malignant or local recurrence |
Axillary surgery staging | |
Low priority | Low grade DCIS |
Discordant biopsy likely benign | |
Breast reconstruction (autologous/implant) | |
Excision of benign breast lesion | |
Prophylactic surgery for high risk asymptomatic patients |
* Triple negative in patients who were either not indicated or not fit for systemic chemotherapy